This result is concordant with myeloid/lymphoid neoplasm with eosinophilia and BCR::FGFR1 rearrangement; therefore, cytoreductive treatment with hydroxyurea and phlebotomies were started according to cytopenia and/or cytosis. The gene discussed is BCR; the disease is Increased total eosinophil count.